Echocardiography Based Algorithm for Spinal Anaesthesia
1 other identifier
interventional
60
1 country
1
Brief Summary
The main aim of the study is to compare the proposed algorithm for preventing and treating spinal hypotension with normal anesthesia management of a spinal anesthesia. The proposed algorithm mainly will depend upon the left ventricular end diastolic area measurement by transthoracic echocardiography to assess the left ventricular preload status and its usefulness in preventing and treating spinal hypotension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 29, 2017
CompletedFirst Posted
Study publicly available on registry
April 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedApril 10, 2017
April 1, 2017
1.1 years
March 29, 2017
April 4, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of hypotension
To compare an ECHO based algorithm of hemodynamic management as compared to standard practice in decreasing the incidence of post spinal hypotension (MAP \>20% of baseline or MAP \<60 mm Hg).
30 minutes
Secondary Outcomes (5)
number of episodes of hypotension.
30 minutes
magnitude of hypotension.
30 minutes
duration of hypotension.
30 minutes
use of IV fluids
30 minutes
use of vasopressors
30 minutes
Study Arms (2)
Gr (E)
EXPERIMENTALThe group in which the proposed algorithm for prevention and treatment of spinal hypotension will be tested with regard to fluid and vasopressor use, by means of echocardiography.
Gr (S)
NO INTERVENTIONThe control group in which the anesthesia (fluid and vasopressor) management will be decided by the attending anesthesiologist
Interventions
Before administration of spinal anesthesia, Echocardiography will be performed to determine the LVEDA. If the LVEDA is more than 10 square cms, the patient will be considered as volume replete and spinal anesthesia will be administered. If the LVEDA is less than 10 square cms, a fluid bolus of 250 ml of a balanced salt solution will be given and LVEDA reassessed. This will be repeated till the LVEDA is more than 10 square cms or fluid bolus has been given twice and still the LVEDA is less than 10 square centimeters, in which case phenylephrine 1-2µg/kg will be given before administering spinal anesthesia.
For treatment of spinal hypotension, in the event of hypotension(defined as a mean arterial pressure less than 60 mm Hg or decrease in mean arterial pressure of more than 20% from the baseline value) after spinal anesthesia, the LVEDA will be assessed. If more than 10 square centimeters, the patient will be considered volume replete and a vasopressor in the form of phenylephrine 1-2µg/kg will be given. If the LVEDA is less than 10 square centimeters, a volume bolus of 250ml will be given. On reassessment if the LVEDA is still less than 10 square centimeters the volume bolus can be repeated. In the event of hypotension persisting in spite of volume resuscitation, phenylephrine 1-2µg/kg will be given.
Eligibility Criteria
You may qualify if:
- \- above 40 years of age presenting for elective lower abdominal or lower limb surgery and eligible to receive a subarachnoid block.
You may not qualify if:
- Patients with contraindications to a central neuraxial block such as pre- existing coagulopathy, local sepsis at site of insertion, ongoing hemodynamic instability (defined as systolic blood pressure\< 90 mm Hg or MAP\< 65mm Hg), unwillingness to undergo a regional anaesthesia, co- existing pregnancy, spinal dysraphism or, previous history of spinal instrumentation or surgery, chest deformity, demonstrated systolic dysfunction on screening echocardiography (defined as LVEF \<50% or, fractional shortening \< 25%), valvular heart disease (known or diagnosed on screening echo), chronic renal or liver disease and unwilling to participate in the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Postgraduate Institute of Medical Education and Research
Chandigarh, Chandigarh, 160015, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sundara Kannan, MBBS
Post Graduate Institute of Medical Education and Research, Chandigarh
- STUDY CHAIR
Bhupesh Kumar, MBBS,MD,DM
Post Graduate Institute of Medical Education and Research, Chandigarh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PRINCIPAL INVESTIGATOR
Study Record Dates
First Submitted
March 29, 2017
First Posted
April 10, 2017
Study Start
April 1, 2016
Primary Completion
May 1, 2017
Study Completion
June 1, 2017
Last Updated
April 10, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share